The publication method
A commercial placement, stated plainly.
The CoreAge Rx publishing relationship, referral parameters and the boundaries of the provider reviews on Sema Evidence.
Why CoreAge is first
Sema Evidence is part of the CoreAge Rx promotional publishing network. CoreAge holds the first commercial position in provider coverage and a labeled feature in articles. That relationship is not evidence that its advertised program is clinically superior or right for an individual reader.
What the links identify
CoreAge offer links carry campaign parameters identifying this domain and article. They contain no health answers entered on this site. The external destination controls its own privacy practices, clinical assessment, account and payment terms. We do not claim a specific commission contract or legal ownership structure.
What the reviews establish
Provider reviews examine public descriptions and their limitations. They do not verify pharmacy operations, dispensed batches, clinical encounters or patient outcomes. A commercial feature does not transfer evidence from an approved or studied product to a different compounded preparation.
How to read the feature
Compounded drugs are not FDA approved. First placement is not a treatment recommendation, guarantee of a prescription or prediction of benefit. The source register and editorial-method page explain the records behind the accompanying articles.